However, CD27+Ly6C− and CD27+Ly6C+ γδ T cells within the tumor microenvironment expressed the same levels of CD160, NKG2A, NKp46, and CD44, with NKG2A expression in KP tumors being an exception. This evidence concerns the gene CD160 and neoplasm.